[The physiological basis of the treatment of arterial hypertension].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000809:Angiotensins / Q000037:antagonists & inhibitors; D002216:Captopril / Q000627:therapeutic use; D002490:Central Nervous System / Q000187:drug effects; D003000:Clonidine / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology*; D008750:Methyldopa / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D012504:Saralasin / Q000627:therapeutic use; D012964:Sodium / Q000494:pharmacology; D000092502:Renin Inhibitors
D000319:Adrenergic beta-Antagonists; D000809:Angiotensins; D002216:Captopril; D003000:Clonidine; D008750:Methyldopa; D012110:Reserpine; D012504:Saralasin; D012964:Sodium; D000092502:Renin Inhibitors
Bases physiologiques du traitement de l'hypertension artérielle.